Global Clinical Trial Supplies Market Size & Outlook
Global clinical trial supplies market, 2018-2030 (US$M)
Related Markets
Global clinical trial supplies market highlights
- The global clinical trial supplies market generated a revenue of USD 2,578.1 million in 2023 and is expected to reach USD 3,974.7 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 6.4% by 2030.
- In terms of segment, phase iii accounted for a revenue of USD 1,359.9 million in 2023.
- Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Mexico is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 2,578.1 million |
| Market revenue in 2030 | USD 3,974.7 million |
| Growth rate | 6.4% (CAGR from 2023 to 2030) |
| Largest segment | Phase iii |
| Fastest growing segment | Phase I |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Phase I, Phase II, Phase III |
Other key industry trends
- In terms of revenue, the North America accounted for 55.5% of the global clinical trial supplies market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Mexico is the fastest growing regional market and is projected to reach USD 14.2 million by 2030.
Phase iii was the largest segment with a revenue share of 52.75% in 2023. Horizon Databook has segmented the Global clinical trial supplies market based on phase i, phase ii, phase iii covering the revenue growth of each sub-segment from 2018 to 2030.
The geographical distribution base of clinical trials is shifting from developed nations to emerging countries. The rising cost of clinical trials and difficulty in patient recruitment has led biopharmaceutical companies to shift towards regions such as Central and Eastern Europe, Asia pacific, Latin America and Middle East for cost efficiency and quick patient recruitment.
Emerging countries also possess greater disease variation compared to the west, where traditional diseases are growing. The greater disease variation among the developing countries helps biopharmaceutical companies to perform clinical trials on rare diseases.
Regions such as Asia Pacific also provides greater economic benefits to biopharmaceutical companies as governments in Singapore and China allocate funds to promote biomedical research in the region. Latin America, where population speak only Portuguese and Spanish, also reduces barriers to informed consent which helps in easy patient recruitment and faster clinical trials.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Trial Supplies Market Scope
Clinical Trial Supplies Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global clinical trial supplies market size, by regions, 2018-2030 (US$M)
Top 10 countries: Clinical trial supplies market size, 2023 (US$M)
Global clinical trial supplies market share, by phase, 2023 & 2030 (%, US$M)
Clinical trial supplies market: Opportunity assessment by country
Global clinical trial supplies market, by region, 2023 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
